Search research articles
Contact Us
Filters
Showing results (701-710 of 759) with videos related to
Page
of 76
Sort By:
American Journal of Hematology
|
June 2, 2017
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma
Toshi Ghosh, Wilson I Gonsalves, Dragan Jevremovic, et al.
Blood Cancer Journal
|
March 5, 2021
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
Patrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Advances
|
June 29, 2019
Impact of acquired del(17p) in multiple myeloma
Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology
|
June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
European Heart Journal. Digital Health
|
May 22, 2024
The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Milagros Pereyra Pietri, Juan M Farina, Ahmed K Mahmoud, et al.
Orphanet Journal of Rare Diseases
|
May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
Thomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
Blood Advances
|
May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study
Donna E Reece, David H Vesole, Smriti Shrestha, et al.
Page
of 76
Search research articles
Search
Showing results (701-710 of 759) with videos related to
Sort By:
Page
of 76
American Journal of Hematology
|
June 2, 2017
The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma
Toshi Ghosh, Wilson I Gonsalves, Dragan Jevremovic, et al.
Blood Cancer Journal
|
March 5, 2021
MASS-FIX for the detection of monoclonal proteins and light chain N-glycosylation in routine clinical practice: a cross-sectional study of 6315 patients
Patrick W Mellors, Surendra Dasari, Mindy C Kohlhagen, et al.
Blood Advances
|
June 29, 2019
Impact of acquired del(17p) in multiple myeloma
Arjun Lakshman, Utkarsh Painuly, S Vincent Rajkumar, et al.
American Journal of Hematology
|
June 4, 2026
Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia
Daniel G Packard, Shaji K Kumar, Angela Dispenzieri, et al.
Blood Cancer Journal
|
April 19, 2025
Risk of lymphoid malignancy associated with cancer predisposition genes
Nicholas J Boddicker, Raphael Mwangi, Dennis P Robinson, et al.
European Heart Journal. Digital Health
|
May 22, 2024
The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Milagros Pereyra Pietri, Juan M Farina, Ahmed K Mahmoud, et al.
Orphanet Journal of Rare Diseases
|
May 7, 2021
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable
Thomas H Brannagan, Michaela Auer-Grumbach, John L Berk, et al.
Blood Advances
|
May 23, 2020
Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma
Patrick W Mellors, Moritz Binder, Rhett P Ketterling, et al.
Blood Cancer Journal
|
September 29, 2025
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 16, 2010
Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study
Donna E Reece, David H Vesole, Smriti Shrestha, et al.
Page
of 76